4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014872
EVP, Chief Development Officer acquired 95,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Poulton Stuart EVP, Chief Development Officer | 2023-02-28 | Grant or award | +95,000 | 159,131 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…